Vanguard Global Advisers’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.63M Sell
8,745
-342
-4% -$158K ﹤0.01% 823
2026
Q1
$4.36M Buy
+9,087
New +$4.65M ﹤0.01% 812

Other funds holding MEDP

Vanguard Global Advisers's MEDP Position: Q2 2026 in Review

Vanguard Global Advisers reduced its Medpace (MEDP) stake by 3.8% in Q2 2026, selling an estimated $158K and leaving 8,745 shares worth $4.63M. The position accounts for ﹤0.01% of the portfolio, ranked #823.

Vanguard Global Advisers first reported a position in MEDP in Q1 2026 and has held it in 2 quarters since. 682 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Vanguard Global Advisers held 8,745 shares of Medpace worth $4.63M as of Q2 2026.
  • Vanguard Global Advisers sold 342 Medpace shares in Q2 2026, an estimated $158K.
  • Medpace made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q2 2026, its #823 holding.
  • Vanguard Global Advisers first reported a position in Medpace in Q1 2026 and has held it in 2 quarters since.
  • 682 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Vanguard Global Advisers's 13F filing for Q2 2026, filed 13 Aug 2026.